NL-OMON35776已完成不适用
A phase I, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]QLT091001 following single oral dose in healthy male subjects - RET HV 03
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- QLT Inc.
- 入组人数
- 6
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Healthy male
排除标准
- •Clinical significant abnormalities at medical research
研究者
相似试验
已完成
不适用
A phase 1, open-label study to investigate the absorption, metabolism, excretion, and mass balance of [14C]pacritinib following a single oral dose in healthy male subjects.Chronic Myeloproliferative Disordersabnormal growth of blood cells in the bone marrowMyeloproliferative disordersNL-OMON41159CTI BioPharma Corporation6
已完成
不适用
A phase I, open label study to investigate the absorption, metabolism and excretion of 14C-ESN-364 in healthy menopausal female volunteers.NL-OMON46563Ogeda6
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism and excretion of 14C-JNJ-63623872 after a single dose in healthy male subjectsInfluenza ARNA-virus10047438NL-OMON42724Janssen-Cilag6
已完成
不适用
A phase 1, open-label study to characterize the absorption, metabolism, and excretion of 14C-JNJ-53718678 after a single oral dose in healthy adult male subjectsRSV10047438NL-OMON43122Janssen Sciences Ireland UC6
已完成
1 期
A mass-balance study of [14C]KDT-3594 in healthy adult maleHealthy conditionJPRN-jRCT2071220057Shimizu Yoshitaka8